A sequel to a previous post comes this ad for Lexapro. Seems nice enough on the first page . . .
. . . but that’s still a lot of fine print to read.
A sequel to a previous post comes this ad for Lexapro. Seems nice enough on the first page . . .
. . . but that’s still a lot of fine print to read.
Get free updates delivered free to your inbox.
Comments are moderated before they are published. Please read the comment policy.